OHB's November Reckoning: Can Technical Wins Translate Into Earnings?
Palantir's Partner Wins Give the Growth Story a Factory Floor
Petrobras Plans November Diesel Imports as Refineries Run Near Capacity
Newmont's Buy Case Meets Its Toughest Test: A Cost Curve That Climbs Into 2027
Bajaj Mobility's Quarterly Profit Faces a Nine-Month Reality Check
Thyssenkrupp's Duisburg Green-Steel Plant Pushed to 2029, With Hydrogen Supply the Real Test
Copper Miners ETF Whipsawed as Political Risk Collides With Tight Supply
Daimler Truck's North American Surge Lifts Quarterly Profit 73% as Order Gap Clouds Outlook
Leonardo's €60 Billion Backlog Faces a Two-Pronged Execution Test
Bechtle's Profit Growth Lags Revenue as Analysts Split on the Upside
Nvidia's $3 Billion Bet on Meta Comes With a Washington Asterisk
Uniper Courts Buyers With 7% Dividend Growth Pledge as Equinor Weighs Joining Brookfield Bid
Coeur Mining's Rainy River Accounting Drag Masks a Quarter of Real Cash Generation
BAT Draws Goldman Upgrade and FDA Clearance for Velo as Capital Group Slips Below 18% Stake
Erste Group Wins Private Banking Plaudits as Analysts Split on Valuation After Upgraded Outlook
Torm Locks In 53% of Fourth-Quarter Earning Days as Dividend and Newbuilds Share the Capital Bill
BAT's C$187.5 Million Organigram Bet Lands Alongside FDA Nod for Velo and a Goldman Upgrade
Ocugen's Bahamas Clearance Opens a Second Clock, With OCU400 Data Still the Judge
Vistra Backs Raised Guidance With $1.5 Billion Buyback Authorization
Nestlé Backs Full-Year Targets as Ski Sponsorship and U.S. Plant Shift Reshape the Story
SoftBank's November Reckoning: Can the Balance Sheet Carry the AI Vision?
Powermax Minerals Pins Financing Hopes on Rights Offering as Losses Deepen
Petrobras Tops 3.5 Million Barrels a Day as P-78 Hits Nameplate and Diesel Imports Return
ABB Keeps Buying Back Stock While Beijing Blocks Its Robotics Sale
Cameco Pairs Dividend With Fresh US$3 Billion Shelf as McArthur River Filing Stays Voluntary
Innodata's $164 Million War Chest Meets Its Biggest Customer Test
E.ON's 5,500-Site Footprint Meets a Two-Broker Bull Case Ahead of November Update
Marvell's Optical DSP Nod and a 79% Data Center Bet Converge on December 1
BioNTech Keeps Its Buy Ratings as Analysts Trim Price Targets and Clinical Data Cuts Both Ways
Novo Nordisk's Oral Wegovy Bet Divides the Street as Liver Data Pile Up
Axa Recasts Investment Leadership as Amiga Specialty Deal Broadens AXA XL Reach
Lynas Ties Pentagon R&D Supply to a Price-Led Quarter—and a December Output Test
Tesla Rallies With Tech Stocks as Investors Weigh Shrinking Capex Against a 44% Profit Slide